Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2279 (LINC02279) is a member of the long intergenic non-coding RNA (lincRNA) family, transcribed from a genomic region not overlapping protein-coding loci[1][5]. Like other lincRNAs, it is thought to function primarily in the regulation of gene expression and possibly chromatin architecture; however, its specific function, disease relevance, and molecular interactions remain unknown due to a lack of published research characterizing this particular transcript in detail. LINC02279 is referenced in genomic databases as a distinct RNA gene, but as of this date, there is no experimental or clinical literature highlighting therapeutic, diagnostic, or prognostic roles for this molecule[1][5][3].
None documented
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2279 (LINC02279).